{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:53:11Z","timestamp":1767178391473,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009842","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000}}],"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005258","name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention","doi-asserted-by":"publisher","award":["5NU38PS004644"],"award-info":[{"award-number":["5NU38PS004644"]}],"id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI153351"],"award-info":[{"award-number":["R01AI153351"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI132606"],"award-info":[{"award-number":["R01AI132606"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI153521"],"award-info":[{"award-number":["R01AI153521"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI112438"],"award-info":[{"award-number":["R01AI112438"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>In the absence of point-of-care gonorrhea diagnostics that report antibiotic susceptibility, gonorrhea treatment is empiric and determined by standardized guidelines. These guidelines are informed by estimates of resistance prevalence from national surveillance systems. We examined whether guidelines informed by local, rather than national, surveillance data could reduce the incidence of gonorrhea and increase the effective lifespan of antibiotics used in treatment guidelines. We used a transmission dynamic model of gonorrhea among men who have sex with men (MSM) in 16 U.S. metropolitan areas to determine whether spatially adaptive treatment guidelines based on local estimates of resistance prevalence can extend the effective lifespan of hypothetical antibiotics. The rate of gonorrhea cases in these metropolitan areas was 5,548 cases per 100,000 MSM in 2017. Under the current strategy of updating the treatment guideline when the prevalence of resistance exceeds 5%, we showed that spatially adaptive guidelines could reduce the annual rate of gonorrhea cases by 200 cases (95% uncertainty interval: 169, 232) per 100,000 MSM population while extending the use of a first-line antibiotic by 0.75 (0.55, 0.95) years. One potential strategy to reduce the incidence of gonorrhea while extending the effective lifespan of antibiotics is to inform treatment guidelines based on local, rather than national, resistance prevalence.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009842","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T13:39:00Z","timestamp":1644413940000},"page":"e1009842","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-5750","authenticated-orcid":true,"given":"Reza","family":"Yaesoubi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-7198","authenticated-orcid":true,"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7713-4267","authenticated-orcid":true,"given":"Thomas L.","family":"Gift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-4051","authenticated-orcid":true,"given":"Sancta B.","family":"St. Cyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5646-1314","authenticated-orcid":true,"given":"Yonatan H.","family":"Grad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"pcbi.1009842.ref001","volume-title":"Sexually Transmitted Disease Surveillance 2018.","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"pcbi.1009842.ref002","unstructured":"World Health Organization. Report on global sexually transmitted infection surveillance, 2018. Geneva: 2018 https:\/\/www.who.int\/reproductivehealth\/publications\/stis-surveillance-2018\/en\/."},{"key":"pcbi.1009842.ref003","unstructured":"Centres for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. 2019"},{"issue":"19","key":"pcbi.1009842.ref004","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.","volume":"379","author":"SN Taylor","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"pcbi.1009842.ref005","article-title":"Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections.","volume":"61","author":"W O\u2019Riordan","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pcbi.1009842.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance\u2014The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.","volume":"65","author":"RD Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"issue":"2","key":"pcbi.1009842.ref007","doi-asserted-by":"crossref","first-page":"e1001598","DOI":"10.1371\/journal.pmed.1001598","article-title":"Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea.","volume":"11","author":"N Low","year":"2014","journal-title":"PLoS Med"},{"issue":"19","key":"pcbi.1009842.ref008","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJMp1812269","article-title":"Neisseria gonorrhoeae\u2014Rising Infection Rates, Dwindling Treatment Options","volume":"379","author":"S Blank","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"pcbi.1009842.ref009","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection","volume":"366","author":"GA Bolan","year":"2012","journal-title":"N Engl J Med"},{"key":"pcbi.1009842.ref010","volume-title":"Sexually Transmitted Disease Surveillance 2015: Gonococcal Isolate Surveillance Project (GISP) Supplement and Profiles.:","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"pcbi.1009842.ref011","unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: 2012 https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501\/en\/."},{"key":"pcbi.1009842.ref012","volume-title":"Sexually Transmitted Disease Surveillance 2017: Gonococcal Isolate Surveillance Project (GISP) Supplement and Profiles.:","author":"Centers for Disease Control and Prevention","year":"2019"},{"issue":"RR-03","key":"pcbi.1009842.ref013","first-page":"1","article-title":"Prevention. Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"KA Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"50","key":"pcbi.1009842.ref014","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020.","volume":"69","author":"S St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"pcbi.1009842.ref015","doi-asserted-by":"crossref","first-page":"e1003077","DOI":"10.1371\/journal.pmed.1003077","article-title":"Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study.","volume":"17","author":"R Yaesoubi","year":"2020","journal-title":"PLoS Med."},{"issue":"4","key":"pcbi.1009842.ref016","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"DI Andersson","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"pcbi.1009842.ref017","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jix450","article-title":"Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea","volume":"216","author":"AR Tuite","year":"2017","journal-title":"J Infect Dis"},{"key":"pcbi.1009842.ref018","volume-title":"Sexually Transmitted Disease Surveillance 2017.:","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"pcbi.1009842.ref019","article-title":"Bayesian Methods for Calibrating Health Policy Models: A Tutorial.","author":"NA Menzies","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"pcbi.1009842.ref020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro.2017.169","article-title":"Neisseria gonorrhoeae host adaptation and pathogenesis","volume":"16","author":"SJ Quillin","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"pcbi.1009842.ref021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/OLQ.0000000000000623","article-title":"Increases in the Rate of Neisseria gonorrhoeae Among Gay, Bisexual and Other Men Who Have Sex With Men-Findings From the Sexually Transmitted Disease Surveillance Network 2010\u20132015.","volume":"44","author":"MR Stenger","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"1","key":"pcbi.1009842.ref022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1071\/SH16099","article-title":"Global travel and HIV\/STI epidemics among MSM: what does the future hold?","volume":"14","author":"VC Lee","year":"2017","journal-title":"Sex Health"},{"issue":"5","key":"pcbi.1009842.ref023","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/OLQ.0000000000000953","article-title":"Assessing Uncertainty in an Anatomical Site-Specific Gonorrhea Transmission Model of Men Who Have Sex With Men.","volume":"46","author":"IH Spicknall","year":"2019","journal-title":"Sex Transm Dis"},{"key":"pcbi.1009842.ref024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.puhe.2016.04.004","article-title":"Identifying variations in adherence to the CDC sexually transmitted disease treatment guidelines of Neisseria gonorrhoeae.","volume":"136","author":"AJ Boyajian","year":"2016","journal-title":"Public Health"},{"key":"pcbi.1009842.ref025","article-title":"Agent-based modelling study of antimicrobial-resistant Neisseria gonorrhoeae transmission in men who have sex with men: towards individualised diagnosis and treatment.","author":"AK Zienkiewicz","year":"2019","journal-title":"Sex Health"},{"key":"pcbi.1009842.ref026","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u2014the rapidly evolving Neisseria gonorrhoeae continues to challenge.","volume":"15","author":"M Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"pcbi.1009842.ref027","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0881-x","article-title":"Detection of antibiotic resistance is essential for gonorrhoea point-of-care testing: a mathematical modelling study.","volume":"15","author":"SM Fingerhuth","year":"2017","journal-title":"Bmc Med"},{"issue":"14","key":"pcbi.1009842.ref028","doi-asserted-by":"crossref","first-page":"321","DOI":"10.15585\/mmwr.mm6814a1","article-title":"Extragenital Chlamydia and Gonorrhea Among Community Venue-Attending Men Who Have Sex with Men\u2014Five Cities, United States, 2017.","volume":"68","author":"ML Johnson Jones","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"pcbi.1009842.ref029","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/003335491212700308","article-title":"A tale of two gonorrhea epidemics: results from the STD surveillance network","volume":"127","author":"LM Newman","year":"2012","journal-title":"Public Health Rep"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009842","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T13:47:29Z","timestamp":1645537649000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009842"}},"subtitle":[],"editor":[{"given":"Dominik","family":"Wodarz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009842","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]}}}